Galapagos NV
GLPG
#4542
Rank
A$3.00 B
Marketcap
A$45.57
Share price
-1.60%
Change (1 day)
11.70%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): A-$0.71

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.48. In 2024 the company made an earnings per share (EPS) of A$1.66 a decrease over its 2023 EPS that were of A$5.05.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$0.71-142.52%
2024A$1.66-67.16%
2023A$5.05-199.64%
2022A-$5.0799.03%
2021A-$2.55-68.98%
2020A-$8.21-298.06%
2019A$4.15-554.64%
2018A-$0.91-77.18%
2017A-$4.00-326.21%
2016A$1.77-134.19%
2015A-$5.17-371.34%
2014A$1.90-445.98%
2013A-$0.5532.88%
2012A-$0.41-82.07%
2011A-$2.31-817.9%
2010A$0.3212.73%
2009A$0.29-120.79%
2008A-$1.37-37.67%
2007A-$2.2039.64%
2006A-$1.5828.17%
2005A-$1.236.25%
2004A-$1.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$15.86-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.34-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$3.41-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.94-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$10.40-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$7.62-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.36-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.87 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.77-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel